Clinical Trials Directory

Trials / Completed

CompletedNCT02723305

Cardiometabolic Profiles of Boys With Klinefelter Syndrome

Cardiometabolic Profiles of Pubertal Boys With Klinefelter Syndrome With or Without One Year of Exogenous Testosterone Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
31 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
Male
Age
12 Years – 17 Years
Healthy volunteers
Not accepted

Summary

This study plans to learn more about how to measure the way the the body's energy system works in boys with Klinefelter syndrome, including the heart, lungs, muscles, and liver. This is important to know so that investigators understand how hormones and an extra X chromosome relate to diseases such as diabetes, extra weight gain, heart disease and liver diseases.

Detailed description

Klinefelter syndrome (KS) is the most common chromosomal abnormality in males and is associated with primary gonadal failure in adolescence and a high morbidity and mortality from cardiovascular-related diseases (CVD) in adulthood. Recent studies in children and adolescent boys with KS have found a high prevalence of CVD risk markers, however the underlying mechanisms have not been explored. Our central hypothesis is that pubertal boys with KS have relative testosterone deficiency resulting in abnormal energy metabolism that predisposes them to later CVD, and that exogenous testosterone will modify these abnormalities. In this study, investigators will measure markers of cardiometabolic risk in pubertal boys with KS.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2016-05-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2016-03-30
Last updated
2022-03-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02723305. Inclusion in this directory is not an endorsement.